Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.60
+0.82 (6.38%)
At close: Jul 25, 2025, 4:00 PM
13.52
-0.08 (-0.55%)
After-hours: Jul 25, 2025, 7:09 PM EDT
Intellia Therapeutics Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$35.11
Upside
+158.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +120.67% | Jun 16, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $74 → $54 | Strong Buy | Maintains | $74 → $54 | +297.20% | Jun 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +120.67% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +120.67% | May 20, 2025 |
| Wedbush | Wedbush | Hold Reiterates $10 | Hold | Reiterates | $10 | -26.44% | May 19, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $55 → $45 | Strong Buy | Maintains | $55 → $45 | +231.00% | May 12, 2025 |
| Citigroup | Citigroup | Hold Maintains $14 → $10 | Hold | Maintains | $14 → $10 | -26.44% | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $68 | Strong Buy | Maintains | $68 | +400.18% | May 9, 2025 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $21 | Hold → Buy | Upgrades | $21 | +54.47% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +120.67% | Mar 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $90 → $50 | Strong Buy | Maintains | $90 → $50 | +267.78% | Mar 4, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $26 | Buy | Maintains | $55 → $26 | +91.25% | Feb 28, 2025 |
| Citigroup | Citigroup | Hold Maintains $12 → $14 | Hold | Maintains | $12 → $14 | +2.98% | Feb 28, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $60 → $50 | Buy | Maintains | $60 → $50 | +267.78% | Feb 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $91 → $68 | Strong Buy | Maintains | $91 → $68 | +400.18% | Feb 28, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $45 → $13 | Buy → Hold | Downgrades | $45 → $13 | -4.38% | Feb 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.